Roots Analysis has done a detailed study on RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

The ‘Global Preventive Vaccines Market, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain.

Prefilled Syringes Market (5th edition), 2019-2030’ report features an extensive study of the current market landscape of prefilled syringes

The ‘Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals

The “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations.

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China.

The concept of RNA interference (RNAi) was identified in the 1980s. It is based on the selective silencing of specific sequences of mRNA, thereby, inhibiting the ability to translate into disease causing proteins.

More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development, claims Roots Analysis

Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions, claims Roots Analysis

More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis

Currently, there are over 240 closures, fabricated using a variety of elastomeric materials, available for use in parenteral primary packaging containers; majority of these products are available in the ready-to-use format, claims Roots Analysis

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

The Global Preventive Vaccines Market is projected to be worth USD 94 billion, by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

The Prefilled Syringes Market is projected to grow at an annualized rate of ~5%, till 2030

The Peptides and Macrocycle Drug Discovery Services Market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

The Elastomeric Closures Market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis

The Chines Biopharmaceutical Contract Manufacturing Market is projected to grow at an annualized rate of ~13%, till 2030

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

The Global Preventive Vaccines Market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

The Prefilled Syringes Market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis

Peptides And Macrocycle Drug Discovery Services Market is projected to reach USD 1.5 Billion by 2030, growing at an annualized rate of 10.5%, claims Roots Analysis

The Chinese Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis

Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030” report features an extensive study of the current market landscape of therapeutic contact lenses, drug-eluting contact lenses, diagnostic

Medical Device CROs Market (2nd Edition), 2020-2030’ report features an extensive study of the current market landscape and future opportunities

Over 270 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices, including therapeutic and diagnostic products

Autoinjectors Market (3rd Edition), 2020-2030’ report features an extensive study of the current market landscape, offering an informed

Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market

Over 55 novel ophthalmic products are currently available / being developed for various therapeutic, diagnostic & monitoring and drug delivery applications; their growing popularity is evident across social media as well, claims Roots Analysis

Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical and clinical research-related services to medical device-focused business entities, claims Roots Analysis

Over 270 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices, including therapeutic and diagnostic products

Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors, most of which are disposable systems that use prefilled syringes as primary drug containers, claims Roots Analysis

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers, claims Roots Analysis

The Next Generation Contact Lenses and Visual Prostheses Market is projected to grow at an annualized rate of 52%, till 2030

The Medical Device CRO Market is projected to grow at an annualized rate of 6.4%, till 2030

The Medical Device Contract Manufacturing Market is projected to grow at an annualized rate of 8%, till 2030

The Global Autoinjectors Market is projected to grow at an annualized rate of ~10% and be worth around USD 2.5 Billion, till 2030

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.

Next Generation Contact Lenses and Visual Prostheses Market is estimated to be worth USD 3.7 billion in 2030, predicts Roots Analysis

Over the years outsourcing has become a popular trend among medical device developers, allowing such companies to leverage the expertise / substantial production capabilities of CMOs / CDMOs in order to gain cost and time related benefits

Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community.

The USD 2.7 billion and USD 600 million (by 2030) financial opportunity within the large volume wearable injectors market for the delivery of insulin and of non-insulin drugs, respectively, has been analyzed across the following segments:

Since the discovery of ultrasound, the field of medical imaging has evolved significantly, offering non-invasive means for physicians to accurately visualize almost all major organ systems for diagnostic purposes.

The first monoclonal antibody, Orthoclone OKT3®, was approved in 1986 by the FDA. Since then, a number of antibody therapeutics (more than 100) have been marketed for the treatment of patients suffering

The microbiome therapies pipeline features 260 drugs under evaluation across different phases of development; contract service providers have become an integral part of the supply chain owing to their technical expertise, claims Roots Analysis

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners that are being actively used for remote monitoring of patients by doctors / physicians

With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis

The Contract Manufacturing Market for Live Biotherapeutics And Microbiome Products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis